Inventor · disambiguated record
Jean Zhao
Also filed as: ZHAO JEAN · ZHAO JEAN J · ZHAO JEAN JIANGUN
12 granted patents·12 pending applications·43 citations·filing 2001–2024
85Inventor score
Files withDANA FARBER CANCER INST INC11GEODE THERAPEUTICS INC2ZHAO JEAN2CRIMSON BIOPHARM INC1GOEL SHORN1
Top patents by PatentIndex Score
24 records- 0194US10544138B2Tricyclic kinase inhibitors of MELK and methods of useDANA FARBER CANCER INST INC·Filed 2016·Granted Jan 28, 2020·12 cites·20 claims
- 0287US6706942B1Molded or extruded articles comprising polyhydroxyalkanoate copolymer compositions having short annealing cycle timesPROCTER & GAMBLE·Filed 2003·Granted Mar 16, 2004·26 cites·24 claims
- 0381US8178317B2Compositions and methods for identifying transforming and tumor suppressor genesROBERTS THOMAS M·Filed 2008·Granted May 15, 2012·4 cites·35 claims
- 0474US9540619B2MELK regulation for the treatment of breast cancerNOVARTIS AG·Filed 2014·Granted Jan 10, 2017·1 cites·7 claims
- 0564US2025019705A1PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING TARGET CANCER INCLUDING BRCA-SPECIFIC siRNA AS ACTIVE INGREDIENTKOREA INST SCI & TECH·Filed 2024·Application pending·0 cites
- 0661US2024239796A1Crystalline polymorphs of epidermal growth factor receptor inhibitor, and compositions and methods thereofCRIMSON BIOPHARM INC·Filed 2022·Application pending·0 cites
- 0758US10960008B2Methods for treating PTEN deficient epithelial cancers using a combination of anti-PI3KBETA and anti-immune checkpoint agentsDANA FARBER CANCER INST INC·Filed 2017·Granted Mar 30, 2021·0 cites·18 claims
- 0856US10254283B2Biomarker for MELK activity and methods of using sameDANA FARBER CANCER INST INC·Filed 2014·Granted Apr 9, 2019·0 cites·18 claims
- 0956US2021267991A1Methods for treating pten deficient epithelial cancers using a combination of anti-pi3kbeta and anti-immune checkpoint agentsDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 1056US2024293405A1(1h-pyrrolo[2,3-b]pyridin-1-yl)pyrimidin-2-yl-amino-phenyl-acrylamide inhibitors of egfr for use in the treatment of brain tumorsZHAO JEAN·Filed 2022·Application pending·0 cites
- 1154US12478665B2Cancer vaccine compositions and methods for using same to prevent and/or treat cancerDANA FARBER CANCER INST INC·Filed 2020·Granted Nov 25, 2025·0 cites·11 claims
- 1253US2025009743A1Methods of treating cancers using sting agonistsDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 1351US2025171461A1Stimulator of interferon genes (sting) modulators, and compositions and methods thereofGEODE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1449US11318139B2Methods for treating brain metastases using combinations of anti-P13K and anti-mTOR agentsDANA FARBER CANCER INST INC·Filed 2017·Granted May 3, 2022·0 cites·15 claims
- 1548US11155556B2Pyrimido-diazepinone kinase scaffold compounds and methods for treating PI3K-mediated disordersDANA FARBER CANCER INST INC·Filed 2017·Granted Oct 26, 2021·0 cites·15 claims
- 1646US2024166617A1Phosphoinositide 3 kinase beta inhibitors and compositions and methods thereofGEODE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1744US10875844B2Salicylate inhibitors of MELK and methods of useDANA FARBER CANCER INST INC·Filed 2016·Granted Dec 29, 2020·0 cites·13 claims
- 1844US2017073687A1MELK Regulation for the Treatment of Breast CancerHUANG XIZHONG·Filed 2016·Application pending·0 cites
- 1944US2020268864A1Cancer vaccine compositions and methods for using same to treat cancerZHAO JEAN·Filed 2018·Application pending·0 cites
- 2041US11366100B2P13K-MTORC1-S6K1 signaling pathway biomarkers predictive of anti-cancer responsesDANA FARBER CANCER INST INC·Filed 2015·Granted Jun 21, 2022·0 cites·4 claims
- 2141US11155857B2Methods for measuring RNA translation ratesDANA FARBER CANCER INST INC·Filed 2017·Granted Oct 26, 2021·0 cites·17 claims
- 2239US2014309221A1Method of inhibiting hamartoma tumor cellsZHAO JEAN J·Filed 2012·Application pending·0 cites
- 2334US2020108066A1Methods for modulating regulatory t cells and immune responses using cdk4/6 inhibitorsGOEL SHORN·Filed 2018·Application pending·0 cites
- 2429US2003001916A1Adaptive multi-image integrated system for lenticular applicationsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jean Zhao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →